Spinocerebellar Ataxia Type 7 (SCA7): First Report of a Systematic Neuropathological Study of the Brain of a Patient with a Very Short Expanded CAG-Repeat

• Published in: Brain pathology (Zurich, Switzerland) Vol. 15; no. 4; pp. 287 - 295
• Main Authors: Rüb, U, Brunt, ER, Gierga, K, Seidel, K, Schultz, C, Schöls, L, Auburger, G, Heinsen, H, Ippel, PF, Glimmerveen, WF, Wittebol-Post, D, Arai, K, Deller, T, de Vos, RAI
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01-10-2005
• Subjects: Aged; Brain - pathology; Female; Humans; Immunohistochemistry; Nerve Degeneration - pathology; Retina - pathology; Spinocerebellar Ataxias - genetics; Spinocerebellar Ataxias - pathology; Trinucleotide Repeat Expansion
• ISSN: 1015-6305; 1750-3639
• DOI: 10.1111/j.1750-3639.2005.tb00113.x

Spinocerebellar ataxia type 7 (ScA7) represents a very rare and severe autosomal dominantly inherited cerebellar ataxia (AdCA). It belongs to the group of CAG‐repeat or polyglutamine diseases with its underlying molecular genetical defect on chromosome 3p12‐p21.1. Here, we performed a systematic study of the neuropathology on unconventional thick serial sections of the first available brain tissue of a genetically confirmed late‐onset SCA7 patient with a very short CAG‐repeat expansion. Along with myelin pallor of a variety of central nervous fiber tracts, we observed i) neurodegeneration in select areas of the cerebral cortex, and ii) widespread nerve cell loss in the cerebellum, thalamus, nuclei of the basal ganglia, and brainstem. In addition, upon immunocytochemical analysis using the anti‐polyglutamine antibody 1C2, immunopositive neuronal intranuclear inclusions bodies (NI) were observed in all cerebellar regions, in all parts of the cerebral cortex, and in telencephalic and brainstem nuclei, irrespective of whether they underwent neurodegeneration. These novel findings provide explanations for a variety of clinical symptoms and paraclinical findings of both our and other SCA7 patients. Finally, our immunocytochemical analysis confirms previous studies which described the presence of NI in obviously degenerated brain and retinal regions as well as in apparently well‐preserved brain regions and retina of SCA7 patients.